$GILD Gets FDA Approval for Non-Hodgkins Lymphoma Treatment
https://www.businesswire.com/news/home/20210305005624/en/U.S.-FDA-Approves-Yescarta%C2%AE-for-Relapsed-or-Refractory-Follicular-Lymphoma-After-Two-or-More-Lines-of-Systemic-Therapy
$GILD Gets FDA Approval for Non-Hodgkins Lymphoma Treatment – chatter @ #wallstreetbets
